Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 1, 2013, Pages

  Sugawara, Koji ^a,b   Zákány, Nóra ^a,c   Hundt, Torsten ^a   Emelianov, Vladimir ^a   Tsuruta, Daisuke ^b   Schäfer, Christian ^d   Kloepper, Jennifer E ^a   Bíró, Tamás ^b   Paus, Ralf ^a,e  

^a UNIVERSITY OF LÜBECK   (Germany)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d ENT Clinic Lübeck   (Germany)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

C Kit; Cannabinoid receptor; Chymase; Endocannabinoid; Mast cell; Mucosa; Nasal polyp; Organ culture; Stem cell factor; Tryptase

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR 1; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS MUCOSA; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; HAIR FOLLICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAMINA PROPRIA; MAST CELL; MAST CELL DEGRANULATION; NOSE POLYP; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION;

EID: 84882852600     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.01.002     Document Type: Article

References (69)

1. Moon TC, St Laurent CD, Morris KE, Marcet C, Yoshimura T, Sekar Y, et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 2010;3:111-28.
2. Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 2010;40:1843-51.
3. Gibbs BF, Ennis M. Isolation and purification of human mast cells and basophils. Methods Mol Med 2001;56:161-76.
4. Howl J, Jones S, Farquhar M. Intracellular delivery of bioactive peptides to RBL-2H3 cells induces beta-hexosaminidase secretion and phospholipase D activation. Chembiochem 2003;4:1312-6.
5. Schierhorn K, Brunnee T, Paus R, Schultz KD, Niehus J, Agha-Mir-Salim P, et al. Gelatin sponge-supported histoculture of human nasal mucosa. In Vitro Cell Dev Biol Anim 1995;31:215-20.
6. Patou J, Holtappels G, Affleck K, Gevaert P, Perez-Novo C, Van Cauwenberge P, et al. Enhanced release of IgE-dependent early phase mediators from nasal polyp tissue. J Inflamm (Lond) 2009;6:11.
7. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, et al. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med 1996;153:551-6.
8. Gilfillan AM, Austin SJ, Metcalfe DD. Mast cell biology: introduction and overview. Adv Exp Med Biol 2011;716:2-12.
9. Robinson DS. The role of the mast cell in asthma: induction of airway hyperres-ponsiveness by interaction with smooth muscle? J Allergy Clin Immunol 2004; 114:58-65.
10. Okayama Y, Ra C, Saito H. Role of mast cells in airway remodeling. Curr Opin Immunol 2007;19:687-93.
11. Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev 2011;242: 31-50.
12. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008;454:445-54.
13. DeMarcantonio MA, Han JK. Nasal polyps: pathogenesis and treatment implications. Otolaryngol Clin North Am 2011;44:685-95.
14. Tan BK, Zirkle W, Chandra RK, Lin D, Conley DB, Peters AT, et al. Atopic profile of patients failing medical therapy for chronic rhinosinusitis. Int Forum Allergy Rhinol 2011;1:88-94.
15. Koh YI, Choi IS. Relationship between nasal and bronchial responsiveness in perennial allergic rhinitic patients with asthma. Int Arch Allergy Immunol 2002;129: 341-7.
16. Hellings PW, Hessel EM, Van Den Oord JJ, Kasran A, Van Hecke P, Ceuppens JL. Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen. Clin Exp Allergy 2001;31:782-90.
17. Otsuka H, Inaba M, Fujikura T, Kunitomo M. Histochemical and functional characteristics of metachromatic cells in the nasal epithelium in allergic rhinitis: studies of nasal scrapings and their dispersed cells. J Allergy Clin Immunol 1995;96: 528-36.
18. Elishmereni M, Alenius HT, Bradding P, Mizrahi S, Shikotra A, Minai-Fleminger Y, et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 2011;66:376-85.
19. Verbruggen K, Van Cauwenberge P, Bachert C. Anti-IgE for the treatment of allergic rhinitis-and eventually nasal polyps? Int Arch Allergy Immunol 2009;148:87-98.
20. Schierhorn K, Brunnee T, Schultz KD, Jahnke V, Kunkel G. Substance-P-induced histamine release from human nasal mucosa in vitro. Int Arch Allergy Immunol 1995;107:109-14.
21. Biro T, Toth IB, Hasko G, Paus R, Pacher P. The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities. Trends Pharmacol Sci 2009;30:411-20.
22. Solinas M, Goldberg SR, Piomelli D. The endocannabinoid system in brain reward processes. Br J Pharmacol 2008;154:369-83.
23. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabi-noid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev 2010;62: 588-631.
24. Liu J, Wang L, Harvey-White J, Huang BX, Kim HY, Luquet S, et al. Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 2008; 54:1-7.
25. Di Marzo V, Piscitelli F, Mechoulam R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol 2011;203:75-104.
26. Cantarella G, Scollo M, Lempereur L, Saccani-Jotti G, Basile F, Bernardini R. Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells. Biochem Pharmacol 2011;82:380-8.
27. Cerrato S, Brazis P, della Valle MF, Miolo A, Puigdemont A. Effects of palmitoy-lethanolamide on immunologically induced histamine, PGD2 and TNFalpha release from canine skin mast cells. Vet Immunol Immunopathol 2010;133:9-15.
28. De Filippis D, D'Amico A, Iuvone T. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 2008; 20(suppl 1):20-5.
29. Sugawara K, Biro T, Tsuruta D, Toth IB, Kromminga A, Zakany N, et al. Endocannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol 2012;129:726-38.
30. Lu Z, Hasse S, Bodo E, Rose C, Funk W, Paus R. Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 2007;16:37-44.
31. Ito N, Sugawara K, Bodo E, Takigawa M, van Beek N, Ito T, et al. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 2010;130:995-1004.
32. Telek A, Biro T, Bodo E, Toth BI, Borbiro I, Kunos G, et al. Inhibition of human hair follicle growth by endo-and exocannabinoids. FASEB J 2007;21:3534-41.
33. Soundararajan A, Dodd GD 3rd, Bao A, Phillips WT, McManus LM, Prihoda TJ, et al. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model. Radiology 2011;261:813-23.
34. Martinez-Suastegui L, Duperray B, Godinez F, Guillen G, Slade A, Aguilar G. Laser-assisted cryosurgery in ex vivo mice hepatic tissue: viability assays using green fluorescent protein. Ann Biomed Eng 2011;39:636-48.
35. Weisenthal LM, Marsden JA, Dill PL, Macaluso CK. A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 1983; 43:749-57.
36. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010;125(suppl):S73-80.
37. Abramson J, Pecht I. Regulation of the mast cell response to the type 1 Fc epsilon receptor. Immunol Rev 2007;217:231-54.
38. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83:4464-8.
39. Okuda M. Functional heterogeneity of airway mast cells. Allergy 1999; 54(suppl 57):50-62.
40. Dobrosi N, Toth BI, Nagy G, Dozsa A, Geczy T, Nagy L, et al. Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling. FASEB J 2008;22:3685-95.
41. Galvao Nascimento N, Sampaio MC, Amaral Olivo R, Teixeira C. Contribution of mast cells to the oedema induced by Bothrops moojeni snake venom and a pharmacological assessment of the inflammatory mediators involved. Toxicon 2010;55: 343-52.
42. Hennino A, Berard F, Guillot I, Saad N, Rozieres A, Nicolas JF. Pathology of urticaria. Clin Rev Allergy Immunol 2006;30:3-11.
43. Oh SW, Pae CI, Lee DK, Jones F, Chiang GK, Kim HO, et al. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 2002;168: 1992-2000.
44. Akimoto S, Ishikawa O, Igarashi Y, Kurosawa M, Miyachi Y Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol 1998;138:399-406.
45. Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, Walls AF, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001;164:858-65.
46. Zhang G, Shao J, Su C, Zhao X, Wang X, Sun X, et al. Distribution change of mast cells in human nasal polyps. Anat Rec (Hoboken) 2012;295:758-63.
47. Takabayashi T, Kato A, Peters AT, Suh LA, Carter R, Norton J, et al. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2012;130:410-20.e5.
48. Lamb JP, Sparrow MP. Three-dimensional mapping of sensory innervation with substance p in porcine bronchial mucosa: comparison with human airways. Am J Respir Crit Care Med 2002;166:1269-81.
49. Joos GF. The role of sensory neuropeptides in the pathogenesis of bronchial asthma. Clin Exp Allergy 1989;19(suppl 1):9-13.
50. Peters EM, Liotiri S, Bodo E, Hagen E, Biro T, Arck PC, et al. Probing the effects of stress mediators on the human hair follicle: substance P holds central position. Am J Pathol 2007;171:1872-86.
51. Arck P, Handjiski B, Hagen E, Pincus M, Bruenahl C, Bienenstock J, et al. Is there a 'gut-brain-skin axis'? Exp Dermatol 2010;19:401-5.
52. Dinh QT, Suhling H, Fischer A, Braun A, Welte T. Innervation of the airways in asthma bronchiale and chronic obstructive pulmonary disease (COPD). Pneumolo-gie 2011;65:283-92.
53. Theoharides TC, Enakuaa S, Sismanopoulos N, Asadi S, Papadimas EC, Angeli-dou A, et al. Contribution of stress to asthma worsening through mast cell activation. Ann Allergy Asthma Immunol 2012;109:14-9.
54. Otsuka H, Kusumi T, Kanai S, Koyama M, Kuno Y, Takizawa R. Stem cell factor mRNA expression and production in human nasal epithelial cells: contribution to the accumulation of mast cells in the nasal epithelium of allergy. J Allergy Clin Immunol 1998;102:757-64.
55. Liu C, Liu Z, Li Z, Wu Y. Molecular regulation of mast cell development and maturation. Mol Biol Rep 2010;37:1993-2001.
56. Qi JC, Li L, Li Y, Moore K, Madigan MC, Katsoulotos G, et al. An antibody raised against in vitro-derived human mast cells identifies mature mast cells and a population of cells that are Fc epsilon RI(1), tryptase(-), and chymase(-) in a variety of human tissues. J Histochem Cytochem 2003;51:643-53.
57. Ohnmacht C, Voehringer D. Basophil effector function and homeostasis during helminth infection. Blood 2009;113:2816-25.
58. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003;3:1-6.
59. Jogie-Brahim S, Min HK, Fukuoka Y, Xia HZ, Schwartz LB. Expression of alpha-tryptase and beta-tryptase by human basophils. J Allergy Clin Immunol 2004;113: 1086-92.
60. Welker P, Grabbe J, Zuberbier T, Guhl S, Henz BM. Mast cell and myeloid marker expression during early in vitro mast cell differentiation from human peripheral blood mononuclear cells. J Invest Dermatol 2000;114:44-50.
61. Sugawara K, Biro T, Tsuruta D, Toth IB, Kromminga A, Zakany N, et al. Endo-cannabinoids limit excessive mast cell maturation and activation in human skin. J Allergy Clin Immunol 2012;129:726-38.e8.
62. Dvorak AM, Massey W, Warner J, Kissell S, Kagey-Sobotka A, Lichtenstein LM. IgE-mediated anaphylactic degranulation of isolated human skin mast cells. Blood 1991;77:569-78.
63. Sugawara K, Tsuruta D, Kobayashi H, Ikeda K, Hopkinson SB, Jones JC, et al. Spatial and temporal control of laminin-332(5) and-511 (10) expression during induction of anagen hair growth. J Histochem Cytochem 2007;55: 43-55.
64. Lu Z, Hasse S, Bodo E, Rose C, Funk W, Paus R. Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 2007;16:37-44.
65. Giannini L, Nistri S, Mastroianni R, Cinci L, Vannacci A, Mariottini C, et al. Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs. J Cell Mol Med 2008;12:2381-94.
66. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83:4464-8.
67. Okuda M. Functional heterogeneity of airway mast cells. Allergy 1999; 54(suppl 57):50-62.
68. Moon TC, St Laurent CD, Morris KE, Marcet C, Yoshimura T, Sekar Y, et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 2010;3:111-28.
69. Xing W, Austen KF, Gurish MF, Jones TG. Protease phenotype of connective tissue and of induced mucosal mast cells in mice is regulated by the tissue. Proc Natl Acad Sci USA 2011;108:14210-5.